Once installed, the elevator will make the three-floor building of the former church accessible to all visitors.
AbbVie announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tavapadon, a novel selective dopamine D1/D5 receptor partial agonist that was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback